Cardiac Pacemaker Market, By Product Type (Single-chamber Pacemaker, Dual-chamber Pacemaker, Biventricular Pacemaker), By Implantability (Implantable Pacemakers and External Pacemakers), By End User (Hospitals, Cardiac Clinics, Ambulatory Surgical Centers), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : May 2024

Code : CMI1765

Pages :197

Formats :

Excel and PDF

Industry : Medical Devices

Regional Analysis

Cardiac Pacemaker Market Regional Insights

To learn more about this report, request sample copy

North America remains the dominant region in the global cardiac pacemaker market and is estimated to hold 37.2% of the market share in 2024. The U.S. leads the regional market and accounts for the major share due to the strong presence of leading pacemaker manufacturers in the country. Factors such as rising geriatric population suffering from cardiovascular diseases, favorable reimbursement policies, and higher healthcare spending have boosted the sales of pacemakers in the US. The region is an early adopter of advanced devices due to the high acceptance of new technologies among physicians and patients. Leading global players such as Medtronic, Abbott, and Boston Scientific have their headquarters in the U.S., allowing them to cater to the regional demands efficiently and maintain their stronghold.

Asia Pacific has shown potential to become the fastest-growing region in the global market. China dominates the Asia Pacific cardiac pacemaker market due to rising incidence of cardiovascular diseases and growing healthcare expenditure. Moreover, the presence of a large patient pool makes the country highly lucrative for pacemaker manufacturers. With improving medical infrastructure and affordability, the adoption of pacemakers is increasing at a rapid pace in China.